My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels.

    Borna C, Lazarowski E, van Heusden C, Ohlin H, Erlinge D.

    Thromb J. 2005 Jul 26;3:10.PMID: 16045804 [PubMed]Related articlesFree article

    2.

    The Clinical Significance of Aspirin Resistance in Patients With Chest Pain.

    Aydinalp A, Atar I, Gulmez O, Atar A, Acikel S, Bozbas H, Ozgul A, Ertan C, Ozin B, Muderrisoglu H.

    Clin Cardiol. 2010 Feb 12. [Epub ahead of print]PMID: 20155858 [PubMed - as supplied by publisher]Related articles

    3.

    Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate.

    Macchi L, Christiaens L, Brabant S, Sorel N, Allal J, Mauco G, Brizard A.

    Thromb Res. 2002 Jul 15;107(1-2):45-9.PMID: 12413588 [PubMed - indexed for MEDLINE]Related articles

    4.

    Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.

    Mannini L, Marcucci R, Paniccia R, Antonucci E, Giglioli C, Valente S, Gori AM, Prisco D, Gensini GF, Abbate R.

    Clin Hemorheol Microcirc. 2006;35(1-2):175-81.PMID: 16899924 [PubMed - indexed for MEDLINE]Related articles

    5.

    Abnormal PFA-100 closure time is associated with increased platelet aggregation in patients presenting with chest pain.

    Atiemo AD, Ng'Alla LS, Vaidya D, Williams MS.

    J Thromb Thrombolysis. 2008 Apr;25(2):173-8. Epub 2007 Jun 7.PMID: 17554594 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.

    Tirnaksiz E, Pamukcu B, Oflaz H, Nisanci Y.

    J Thromb Thrombolysis. 2009 Jan;27(1):24-8. Epub 2007 Oct 5.PMID: 17917708 [PubMed - indexed for MEDLINE]Related articles

    7.

    The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.

    Pamukcu B, Oflaz H, Oncul A, Umman B, Mercanoglu F, Ozcan M, Meric M, Nisanci Y.

    J Thromb Thrombolysis. 2006 Oct;22(2):103-10.PMID: 17008975 [PubMed - indexed for MEDLINE]Related articles

    8.

    Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease.

    Pamukcu B, Oflaz H, Onur I, Midilli K, Yilmaz G, Yilmaz E, Nisanci Y.

    Circ J. 2008 Jan;72(1):61-6.PMID: 18159101 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.

    Bierend A, Rau T, Maas R, Schwedhelm E, Böger RH.

    Br J Clin Pharmacol. 2008 Apr;65(4):540-7. Epub 2007 Nov 8.PMID: 17995973 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Evaluation of platelet function in aspirin treated patients with CAD.

    Williams MS, Kickler TS, Vaidya D, Ng'alla LS, Bush DE.

    J Thromb Thrombolysis. 2006 Jun;21(3):241-7.PMID: 16683216 [PubMed - indexed for MEDLINE]Related articles

    11.

    P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.

    van der Zee PM, Biró E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R.

    Clin Chem. 2006 Apr;52(4):657-64. Epub 2006 Jan 26.PMID: 16439610 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.

    Acikel S, Yildirir A, Aydinalp A, Bal U, Kaynar G, Ozin B, Muderrisoglu H.

    Blood Coagul Fibrinolysis. 2009 Sep;20(6):427-32.PMID: 19542882 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation]

    Morel O, Viellard C, Faure A, Jesel L, Ohlmann P, Desprez D, Chauvin M, Roul G, Grunebaum L, Bareiss P.

    Ann Cardiol Angeiol (Paris). 2007 Jan;56(1):21-9. French. PMID: 17343035 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prognostic significance of platelet function in the early phase of ST-elevation myocardial infarction treated with primary angioplasty.

    Huczek Z, Filipiak KJ, Kochman J, Piatkowski R, Grabowski M, Roik M, Kochanowski J, Opolski G.

    Med Sci Monit. 2008 Mar;14(3):CR144-51.PMID: 18301358 [PubMed - indexed for MEDLINE]Related articles

    15.

    Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.

    Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS.

    J Am Coll Cardiol. 2006 Jan 3;47(1):27-33. Epub 2005 Dec 9.PMID: 16386660 [PubMed - indexed for MEDLINE]Related articles

    16.

    Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.

    Malek LA, Grabowski M, Spiewak M, Filipiak KJ, Szpotanska M, Imiela T, Huczek Z, Bobilewicz D, Opolski G.

    J Thromb Thrombolysis. 2007 Dec;24(3):301-5. Epub 2007 Apr 3.PMID: 17404690 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).

    Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE, Turco M, Garcia E, Guagliumi G, Iwaoka RS, Mehran R, O'Neill WW, Lansky AJ, Griffin JJ; CADILLAC Investigators.

    Am J Cardiol. 2006 Aug 1;98(3):331-7. Epub 2006 Jun 9.PMID: 16860018 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.

    Stef G, Csiszar A, Ziangmin Z, Ferdinandy P, Ungvari Z, Veress G.

    Pharmacol Rep. 2007 Jul-Aug;59(4):428-36.PMID: 17901572 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone.

    Konopka A, Spychalska J, Sitkiewicz D, Zdebska E, Pilichowska I, Piotrowski W, Stepińska J.

    Am J Cardiovasc Drugs. 2007;7(6):433-9.PMID: 18076210 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

    Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

    Thromb Haemost. 2007 Dec;98(6):1316-22.PMID: 18064330 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk